The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s lactose intolerance treatment market report forecasts the lactose intolerance treatment market size to grow to $39.18 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

Learn More On The Lactose Intolerance Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/lactose-intolerance-treatment-global-market-report

Lactose Intolerance Treatment Market Size Forecast
The global lactose intolerance treatment market is expected to grow from $28.38 billion in 2022 to $30.38 billion in 2023 at a compound annual growth rate (CAGR) of 7.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global lactose intolerance treatment market is expected to grow to $39.18 billion in 2027 at a CAGR of 6.6%.

North America held the largest lactose intolerance treatment market share.

Key Lactose Intolerance Treatment Market Driver ­– Increase In The Incidences Of Small Intestine Diseases
According to a survey from the United European Gastroenterology (UEG), an Austria-based non-profit organisation, more than 300 million individuals in Europe will suffer from digestive disorders by October 2022. Digestive illnesses cost 0.12% of GDP, which amounts to a potential cost of $20 billion in Europe in 2021, and the predicted cost of averting productivity losses in 2019 was $11.4 billion. This will rise to $34.2 billion in the future for 75% reductions. As a result, rising prevalence of small intestinal disorders are propelling the lactose intolerance therapy market forward.

Request for A Sample Of The Global Lactose Intolerance Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9478&type=smp

Key Lactose Intolerance Treatment Market Trend – Product Innovation
Major lactose intolerance treatment market players are focusing on providing unique solutions to strengthen their market position. For example, in March 2020, Novozymes A/S, a biotechnology firm located in Denmark, developed Saphera Fibre, a novel lactase enzyme that decreases sugars without compromising sweetness, thereby improving the nutritional profile of dairy products. While allowing for low lactose claims, it also increases dietary fibre and increases lactose protein fibres and enzymes.

Lactose Intolerance Treatment Market Segment
1) By Treatment: Food Supplements, Enzyme Lactase Supplements, Probiotics, Other Treatments
2) By Intolerance Type: Primary Lactose Intolerance, Secondary Lactose Intolerance, Congenital Lactose Intolerance, Developmental Lactose Intolerance
3) By Route of Administration: Oral, Injectable
4) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

Lactose Intolerance Treatment Market Major Players and Strategies
Major players in the lactose intolerance treatment market are Johnson and Johnson Services Inc., Abbott Laboratories, Novo Nordisk A/S, Macleods Pharmaceuticals Ltd., Walter Bushnell, Nature’s Way Brands, Profarma Distribuidora Produtos Farmaceuticos SA, Recordati S.p.A, Amgen Inc., Ganeden Inc., Deerland Probiotics & Enzymes Inc., Novozymes A/S, Cargill Incorporated., Dean Foods, AstraZeneca Plc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals Inc., Nestle S.A., Aptus Biotech S.L., and Gelda Scientific And Industrial Development.

Qualigen Therapeutics Inc., a biotechnology company based in the United States, paid $40.8 million for Ritter Pharmaceuticals Inc. in May 2020. With this acquisition, Qualigen Therapeutics Inc. intends to develop therapeutic solutions that alter the gut microbiome to treat gastrointestinal illnesses while also expanding its market services globally. Ritter Pharmaceuticals Inc. is a pharmaceutical firm established in the United States that manufactures nutritional supplements that are claimed to alleviate the symptoms of lactose intolerance.

The Lactose Intolerance Treatment Global Market Report 2023 covers regional data on lactose intolerance treatment market size, lactose intolerance treatment market trends and drivers, opportunities, strategies, and lactose intolerance treatment market competitor analysis. The countries covered in the lactose intolerance treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Lactose intolerance treatment is used to treat a disorder that causes digestive discomfort. It is a digestive condition caused by a lack of lactase production. Abdominal pain, flatulence, bloating, cramps, acidity, and diarrhoea are all symptoms of this illness. Lactose intolerance is treated by a natural enzyme (lactase) produced by the body.

View More Reports Related To The Lactose Intolerance Treatment Market –
Lactose Free Food Global Market Report 2023
Lactose Global Market Report 2023
Lactose-Free Dairy Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: